EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Ultrasound‐Guided Stellate Ganglion Block in Fibromyalgia: A Randomized, Single‐Center, Single‐Blind, Sham‐Controlled Trial

Yagmur Can Dadakci iD

Pain Research and Management · 2026-01 · 2026 (1)

DOI: 10.1155/prm/4146674 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Pain Research and Management, online erschienen am 30.07.2026. Verfasst von Yagmur Can Dadakci. Beteiligte Einrichtung: Department of Algology, Sanliurfa Egitim ve Arastirma Hastanesi, 63290, Sanliurfa, Turkey. Hauptthemen laut MEDLINE: Fibromyalgia, Stellate Ganglion, Autonomic Nerve Block, Ultrasonography, Interventional. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Fibromyalgia is a chronic pain syndrome characterized by widespread pain, fatigue, and sleep disturbance. Many patients remain symptomatic despite guideline‐concordant pharmacologic therapy. Stellate ganglion block (SGB) modulates sympathetic activity and may provide an adjunctive option for fibromyalgia‐related pain.

Methods

In this single‐center, randomized, single‐blind, sham‐controlled trial, adults fulfilling the 2016 American College of Rheumatology criteria and receiving stable duloxetine 60 mg/day were randomized 1:1 to ultrasound‐guided SGB or a sham procedure. Two procedures were performed 1 week apart. The primary endpoint was change in the Fibromyalgia Impact Questionnaire Revised (FIQR) total score from baseline to 1 week. Secondary endpoints included FIQR change at 1 month, pain intensity on an 11‐point Numerical Rating Scale (NRS), and FIQR responder rates (≥ 30% and ≥ 50% improvement). Primary analyses were per‐protocol ( n = 60), with modified intention‐to‐treat (mITT, n = 60) and last observation carried forward (LOCF, n = 68) sensitivity analyses. ANCOVA was adjusted for baseline FIQR.

Results

Of 108 screened patients, 68 were randomized (SGB n = 33; control n = 35); 60 (30 per group) completed all assessments. Baseline FIQR was 87.7 ± 7.1 in the SGB group and 82.0 ± 11.3 in controls. At 1 week, FIQR decreased to 53.4 ± 19.0 with SGB versus 77.2 ± 16.3 with control; at 1 month, FIQR was 63.1 ± 20.3 versus 80.2 ± 10.7, respectively. ANCOVA‐adjusted between‐group differences in FIQR change favored SGB by −29.9 points (95% CI −37.9 to −21.9; p < 0.001) at 1 week and −22.9 points (95% CI −30.1 to −15.7; p < 0.001) at 1 month. NRS pain reductions were also significantly greater with SGB at both time points (adjusted difference −3.1 points, 95% CI −4.1 to −2.0, p < 0.001 at 1 week; −2.6 points, 95% CI −3.6 to −1.6, p < 0.001 at 1 month). No serious complications occurred; adverse events were transient and mild.

Conclusion

In treatment‐resistant fibromyalgia patients receiving stable duloxetine, ultrasound‐guided SGB produced clinically meaningful short‐term improvements in fibromyalgia impact and pain with an acceptable safety profile. However, the large effect sizes should be interpreted cautiously given potential unblinding and placebo effects. Larger, multicenter trials with longer follow‐up, objective outcome measures, and formal blinding assessment are warranted. Trial Registration: ClinicalTrials.gov Identifier: NCT07343128

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibromyalgiaStellate GanglionAutonomic Nerve BlockUltrasonography, InterventionalHumansSingle-Blind MethodFemaleMiddle AgedMalePain MeasurementTreatment OutcomeAdultDuloxetine Hydrochloride

Stichwörter der Autor:innen

chronic painfibromyalgiainterventional pain managementnumerical rating scalerandomized controlled trialstellate ganglion blocksympathetic nervous system

Substanzen

Duloxetine Hydrochloride

Autor:innen und Institutionen

  • Department of Algology, Sanliurfa Egitim ve Arastirma Hastanesi, 63290, Sanliurfa, Turkey.
  • Department of Algology, Sanliurfa Education and Research Hospital, Sanliurfa, Turkey, sueadh.gov.tr.

ORCID-Profile: Yagmur Can Dadakci

Zitieren

APA

Dadakci, Y. C. (2026). Ultrasound‐Guided Stellate Ganglion Block in Fibromyalgia: A Randomized, Single‐Center, Single‐Blind, Sham‐Controlled Trial. Pain Research and Management, 2026(1). https://doi.org/10.1155/prm/4146674

Vancouver

Dadakci YC. Ultrasound‐Guided Stellate Ganglion Block in Fibromyalgia: A Randomized, Single‐Center, Single‐Blind, Sham‐Controlled Trial. Pain Research and Management. 2026;2026(1). doi:10.1155/prm/4146674

BibTeX
@article{Dadakci2026,
  author = {Dadakci, Yagmur Can},
  title = {Ultrasound‐Guided Stellate Ganglion Block in Fibromyalgia: A Randomized, Single‐Center, Single‐Blind, Sham‐Controlled Trial},
  journal = {Pain Research and Management},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/prm/4146674}
}
Kostenlos starten →